13D/13G Filings - AVORO CAPITAL ADVISORS LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-14
09:40 am
Purchase
2022-12-3113GMonte Rosa Therapeutics, Inc.
GLUE
AVORO CAPITAL ADVISORS LLC4,325,000
8.900%
1,013,566increase
(+30.61%)
Filing
History
2023-02-14
09:38 am
Purchase
2022-12-3113GMersana Therapeutics, Inc.
MRSN
AVORO CAPITAL ADVISORS LLC7,550,000
7.600%
750,000increase
(+11.03%)
Filing
History
2023-02-14
09:37 am
Sale
2022-12-3113GIVERIC bio, Inc.
ISEE
AVORO CAPITAL ADVISORS LLC6,750,000
4.960%
-500,000decrease
(-6.90%)
Filing
History
2023-02-14
09:37 am
Purchase
2022-12-3113GMadrigal Pharmaceuticals, Inc.
MDGL
AVORO CAPITAL ADVISORS LLC1,660,000
9.700%
235,000increase
(+16.49%)
Filing
History
2023-02-14
09:37 am
Purchase
2022-12-3113GKymera Therapeutics, Inc.
KYMR
AVORO CAPITAL ADVISORS LLC3,850,000
7.000%
3,850,000increase
(New Position)
Filing
History
2023-02-14
09:36 am
Purchase
2022-12-3113GApellis Pharmaceuticals, Inc.
APLS
AVORO CAPITAL ADVISORS LLC10,625,000
9.600%
2,069,445increase
(+24.19%)
Filing
History
2023-02-14
09:36 am
Sale
2022-12-3113GMarinus Pharmaceuticals, Inc.
MRNS
AVORO CAPITAL ADVISORS LLC3,150,000
6.300%
-85,000decrease
(-2.63%)
Filing
History
2023-02-14
09:35 am
Purchase
2022-12-3113GAmicus Therapeutics, Inc.
FOLD
AVORO CAPITAL ADVISORS LLC26,800,000
9.500%
8,300,000increase
(+44.86%)
Filing
History
2023-02-14
09:35 am
Purchase
2022-12-3113GPMV Pharmaceuticals, Inc.
PMVP
AVORO CAPITAL ADVISORS LLC3,060,000
6.700%
1,595,000increase
(+108.87%)
Filing
History
2023-02-14
09:34 am
Sale
2022-12-3113GUnited Therapeutics Corporation
UTHR
AVORO CAPITAL ADVISORS LLC2,865,000
6.300%
-170,000decrease
(-5.60%)
Filing
History
2023-02-14
09:34 am
Purchase
2022-12-3113GMirati Therapeutics, Inc.
MRTX
AVORO CAPITAL ADVISORS LLC5,555,555
9.600%
480,555increase
(+9.47%)
Filing
History
2023-02-14
09:33 am
Purchase
2022-12-3113GKrystal Biotech, Inc.
KRYS
AVORO CAPITAL ADVISORS LLC1,410,000
5.500%
1,410,000increase
(New Position)
Filing
History
2023-02-14
09:33 am
Purchase
2022-12-3113GAscendis Pharma A/S
ASND
AVORO CAPITAL ADVISORS LLC3,100,000
5.400%
3,100,000increase
(New Position)
Filing
History
2023-02-14
09:32 am
Sale
2022-12-3113GKura Oncology, Inc.
KURA
AVORO CAPITAL ADVISORS LLC3,105,000
4.500%
-895,000decrease
(-22.38%)
Filing
History
2023-02-14
09:32 am
Purchase
2022-12-3113GDICE Therapeutics, Inc.
DICE
AVORO CAPITAL ADVISORS LLC2,525,555
5.300%
2,525,555increase
(New Position)
Filing
History
2023-02-14
09:31 am
Sale
2022-12-3113GIovance Biotherapeutics, Inc.
IOVA
AVORO CAPITAL ADVISORS LLC7,020,000
4.400%
-1,655,000decrease
(-19.08%)
Filing
History
2023-02-14
09:30 am
Sale
2022-12-3113GAdverum Biotechnologies, Inc.
ADVM
AVORO CAPITAL ADVISORS LLC0
0.000%
-695,000decrease
(Position Closed)
Filing
History
2022-09-26
5:27 pm
Purchase
2022-09-2213DAadi Bioscience, Inc.
AADI
AVORO CAPITAL ADVISORS LLC3,471,752
14.400%
1,260,000increase
(+56.97%)
Filing
History
2022-02-11
10:09 am
Unchanged
2021-12-3113GPOINT Biopharma Global Inc.
PNT
AVORO CAPITAL ADVISORS LLC0
0.000%
0
(Unchanged)
Filing
History
2022-02-11
10:08 am
Sale
2021-12-3113GRelmada Therapeutics, Inc.
RLMD
AVORO CAPITAL ADVISORS LLC0
0.000%
-1,525,000decrease
(Position Closed)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, Next